作为抗癌剂的胺功能化新型皮罗罗-皮里米丁衍生物:合成,表征和分子对接研究
Praveen Kumar Bandaru1, Satya Kameswara Rao Nidasanametla2, Pulipaka Shyamala1
1Department of Chemistry, Andhra University, Vishakhapatnam, Andhra Pradesh, India.
Anti-cancer agents in medicinal chemistry
|November 7, 2024
概括
新的pyrazolo胺衍生物被合成并测试了抗癌性质. 一些衍生品显示出显著的抗癌活性和有前途的激酶结合,表明作为新的癌症疗法的潜力.
科学领域:
- 药用化学 医学化学
- 药物发现 药物发现 药物发现
- 有机合成 有机合成
背景情况:
- 激酶抑制剂对于癌症治疗至关重要.
- 皮拉佐罗胺衍生物显示出作为抗癌剂的前途.
研究的目的:
- 合成新型的pyrazolo胺衍生物 (5a-5r).
- 评估分子对接与Janus激酶1 (JAK1),Janus激酶2 (JAK2) 和循环素依赖激酶4 (CDK4) 相比.
- 评估针对MCF-7,SET-2和HCT-116细胞系的抗癌活性.
主要方法:
- 皮拉二胺衍生物的多步合成.
- 使用NMR,质谱和HRMS进行结构阐明.
- 分子对接和体外抗癌活性测定.
主要成果:
- 5a-5r.衍生物的成功合成和结构确认.
- 在分子对接研究中观察到有前途的结合亲缘关系,特别是对于异环衍生物.
- 显示出显著的抗癌活性,其中一些衍生品显示IC50值与多克索鲁比相当.
结论:
- 合成的pyrazolo-pyrimidine衍生物显示出作为化合物的潜力.
- 含有亚和异环分子部分的衍生物具有显著的抗癌活性.
- 这些有前途的抗癌药物需要进一步开发.
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:34Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K